Assignee
NYCOMED GMBH
DE49 patents
Top patents by PatentIndex Score
US7951398B2May 31, 2011
Pharmaceutical preparation comprising an active dispersed on a matrix
NYCOMED GMBH50 citations97
US8003798B2Aug 23, 2011
Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
NYCOMED GMBH9 citations92
US7951397B2May 31, 2011
Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
NYCOMED GMBH13 citations92
US7632844B2Dec 15, 2009
2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
NYCOMED GMBH17 citations92
US7470791B2Dec 30, 2008
Process for the preparation of roflumilast
NYCOMED GMBH20 citations92
USD582544SDec 9, 2008
Metered dose inhaler
NYCOMED GMBH45 citations92
US7423046B2Sep 9, 2008
3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
NYCOMED GMBH21 citations92
US7329676B2Feb 12, 2008
2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
NYCOMED GMBH28 citations92
US7641050B2Jan 5, 2010
Medicine pack
NYCOMED GMBH31 citations86
USD580547SNov 11, 2008
Tablet
NYCOMED GMBH29 citations86
US7794752B1Sep 14, 2010
Preparation and administration form comprising an acid-labile active compound
NYCOMED GMBH10 citations84
US7790198B2Sep 7, 2010
Preparation and administration form comprising an acid-labile active compound
NYCOMED GMBH8 citations84
US7785630B2Aug 31, 2010
Preparation and administration form comprising an acid-labile active compound
NYCOMED GMBH10 citations84
US7531540B2May 12, 2009
Phthalazinone-piperidino-derivatives as PDE4 inhibitors
NYCOMED GMBH9 citations84
US7357943B2Apr 15, 2008
Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
NYCOMED GMBH13 citations84
US7351723B2Apr 1, 2008
Freeze-dried pantoprazole preparation and pantoprazole injection
NYCOMED GMBH10 citations84
US7892209B2Feb 22, 2011
Arrangement comprising a catheter and connector piece, and valve for passage of a catheter
NYCOMED GMBH21 citations83
US7851472B2Dec 14, 2010
Triazolophthalazines
NYCOMED GMBH11 citations83
US7671050B2Mar 2, 2010
Triazolophthalazines
NYCOMED GMBH10 citations83
US7585872B2Sep 8, 2009
Guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (PDE) 4 inhibitors
NYCOMED GMBH17 citations83
US7718668B2May 18, 2010
Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
NYCOMED GMBH11 citations82
US7666872B2Feb 23, 2010
Use for PDE5 inhibitors
NYCOMED GMBH8 citations77
US8371292B2Feb 12, 2013
Use of ciclesonide for the treatment of respiratory diseases
NYCOMED GMBH12 citations73
US8354535B2Jan 15, 2013
Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
NYCOMED GMBH4 citations71
US7494990B2Feb 24, 2009
2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors
NYCOMED GMBH7 citations71
US7988999B2Aug 2, 2011
Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
NYCOMED GMBH6 citations63
US7279488B2Oct 9, 2007
Imidazopyridine-derivatives as inducible no-synthase inhibitors
NYCOMED GMBH4 citations63
US8455653B2Jun 4, 2013
Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
NYCOMED GMBH2 citations62
US7776893B2Aug 17, 2010
Use of PDE4 inhibitors for the treatment of diabetes mellitus
NYCOMED GMBH3 citations62
US7468433B2Dec 23, 2008
Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation
NYCOMED GMBH2 citations62
US8754218B2Jun 17, 2014
Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives
NYCOMED GMBH2 citations60
US7820669B2Oct 26, 2010
2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors
NYCOMED GMBH3 citations60
US8383611B1Feb 26, 2013
Ciclesonide containing aqueous pharmaceutical composition
NYCOMED GMBH2 citations59
US8029811B2Oct 4, 2011
Stabilized pharmaceutical product
NYCOMED GMBH1 citations59
US7838521B2Nov 23, 2010
3-oxa-10-aza-phenanthrenes
NYCOMED GMBH4 citations59
US7736673B2Jun 15, 2010
Stabilized pharmaceutical product
NYCOMED GMBH3 citations59
US7452998B2Nov 18, 2008
Process for preparing optically pure active compounds
NYCOMED GMBH3 citations59
US7301030B2Nov 27, 2007
Process for preparing (S)-pantoprazole
NYCOMED GMBH3 citations59
US8017633B2Sep 13, 2011
Roflumilast for the treatment of diabetes mellitus
NYCOMED GMBH4 citations56
US7671068B2Mar 2, 2010
N-(alkoxyalkyl) carbamoyl-substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE ¾ inhibitors
NYCOMED GMBH0 citations52
US7402321B2Jul 22, 2008
Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
NYCOMED GMBH0 citations51
US7589205B2Sep 15, 2009
3-thia-10-aza-phenanthrene derivatives
NYCOMED GMBH1 citations49
US7879832B2Feb 1, 2011
Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
NYCOMED GMBH0 citations48
US7470704B2Dec 30, 2008
Benzonaphthyridines
NYCOMED GMBH0 citations46
US7879833B2Feb 1, 2011
Combination medicament
NYCOMED GMBH0 citations45
US7629361B2Dec 8, 2009
Salt of (S)-pantoprazole and its hydrates
NYCOMED GMBH1 citations45
US7601737B2Oct 13, 2009
Isotopically substituted proton pump inhibitors
NYCOMED GMBH1 citations44
US7790710B2Sep 7, 2010
Imidazopyridine derivatives useful as iNOS inhibitors
NYCOMED GMBH0 citations36
US7947744B2May 24, 2011
Stable pharmaceutical products
NYCOMED GMBH0 citations33